ask="4.89"
ask_size="400"
average_daily_volume="306313"
bid="2.15"
bid_size="100"
book_value="3.30"
change="+0.21"
change_from_200_day_moving_average="1.42"
change_from_50_day_moving_average="0.21"
change_from_52_week_high="-2.37"
change_From_52_week_low="3.53"
change_in_percent="+5.07%"
close="4.35"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.37"
ebitda="-44.46M"
eps_estimate_current_year="5.02"
eps_estimate_next_quarter="-0.43"
eps_estimate_next_year="-1.53"
ex_dividend_date="N/A"
float_shares="13906000"
high="4.56"
high_52_weeks="6.72"
last_trade_date="3/10/2017"
last_trade_price="4.35"
last_trade_size="3467"
last_trade_time="4:00pm"
low="4.20"
low_52_weeks="0.82"
market_capitalization="98.14M"
moving_average_200_day="2.93"
moving_average_50_day="4.14"
name="Cascadian Therapeutics
Inc."
notes="N/A"
one_year_target_price="390.00"
open="4.20"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+48.38%"
percent_change_from_50_day_moving_average="+4.98%"
percent_change_from_52_week_high="-35.27%"
percent_change_from_52_week_low="+430.49%"
previous_close="4.14"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.26"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="22562000"
short_ratio="2.05"
stock_exchange="NMS"
symbol="CASC"
volume="381834"
weeks_range_52="0.82 - 6.72"
